Genetesis
Manufacturing · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5412 Courseview Dr Ste 150, Mason, Ohio,...Phone Number
(513) 715-5045Website
www.genetesis.comRevenue
$7.5 MillionIndustry
About Genetesis
Genetesis is a healthcare company that has developed the CardioFlux Membership program, aimed at transforming preventive cardiac care and addressing heart disease. Their flagship product, CardioFlux, utilizes magnetocardiography to detect functionally significant ischemia quickly and non-invasively. The company targets patients experiencing chest pain and healthcare professionals seeking efficient diagnostic solutions. With a focus on improving hospital workflows and reducing patient wait times, Genetesis is committed to enhancing the standard of care in cardiac imaging.Explore more
Genetesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Genetesis
Compare insights from companies similar to Genetesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Genetesis
$7.5M
11-50
Private
$35.9M
2013
RS
Robert SokolowskiVice President, Clinical, Quality & Regulatory Affairs
Genetesis Tech Stack
A closer look at the technologies used by Genetesis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Genetesis
Sign Up For FreeTo access detailed company insights
Genetesis is a healthcare company that has developed the CardioFlux Membership program, aimed at transforming preventive cardiac care and addressing heart disease. Their flagship product, CardioFlux, utilizes magnetocardiography to detect functionally significant ischemia quickly and non-invasively. The company targets patients experiencing chest p... Read More
